ArticleBMC health services research2022

Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.

Sylvie Boyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.